Current Investigations
Securities Fraud
Governance & Derivative
Mergers & Acquisitions
Final Approval of $27.5 Million Settlement Granted in Aimmune Merger Litigation
After more than four years of litigation, the Hon. Maxine Chesney entered a Final Judgment approving a $27.5 million settlement for the Class in a Class action against Aimmune Therapeutics.
KSF Wins Class Certification in Credit Suisse Securities Litigation
On July 7, 2025, the court certified a class of shareholders and noteholders in In re: Credit Suisse Securities Fraud Class Actions (Diabat), No. 1:23-cv-05874-CM (S.D.N.Y.), a securities fraud class action pending in the United States District Court for the Southern District of New York.
Final Approval of $13 Million Settlement Granted in CarLotz Securities Litigation
On July 7, 2025, a Final Judgment of $13 million settlement of the Class’s claims in Hogan v. Pilgrim’s Pride Corporation et al., was approved.
Final Approval of $41.5 Million Settlement Granted in Pilgrim’s Pride Securities Litigation
On June 17, 2025, a Final Judgment of $41.5 million settlement of the Class’s claims in Hogan v. Pilgrim’s Pride Corporation et al., was approved.
Kahn Swick & Foti, LLC Among Top Ten Law Firms of 2024
Kahn Swick & Foti, LLC is among the Top Ten Plaintiff Law Firms by Total Cash Amount of 2024 North American Securities-Related Class Action Settlements.